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Abstract
Background: The objective of this study was to examine the Minimum Data Set (MDS) and
Geriatric Depression Scale (GDS) as measures of depression among nursing home residents.
Methods: The data for this study were baseline, pre-intervention assessment data from a research
study involving nine nursing homes and 704 residents in Massachusetts. Trained research nurses
assessed residents using the MDS and the GDS 15-item version. Demographic, psychiatric, and
cognitive data were obtained using the MDS. Level of depression was operationalized as: (1) a sum
of the MDS Depression items; (2) the MDS Depression Rating Scale; (3) the 15-item GDS; and (4)
the five-item GDS. We compared missing data, floor effects, means, internal consistency reliability,
scale score correlation, and ability to identify residents with conspicuous depression (chart
diagnosis or use of antidepressant) across cognitive impairment strata.
Results: The GDS and MDS Depression scales were uncorrelated. Nevertheless, both MDS and
GDS measures demonstrated adequate internal consistency reliability. The MDS suggested greater
depression among those with cognitive impairment, whereas the GDS suggested a more severe
depression among those with better cognitive functioning. The GDS was limited by missing data;
the DRS by a larger floor effect. The DRS was more strongly correlated with conspicuous
depression, but only among those with cognitive impairment.
Conclusions: The MDS Depression items and GDS identify different elements of depression. This
may be due to differences in the manifest symptom content and/or the self-report nature of the
GDS versus the observer-rated MDS. Our findings suggest that the GDS and the MDS are not
interchangeable measures of depression.
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Depression is common among residents of nursing
homes [1]. Of the many instruments used to identify
depression in the elderly, the Geriatric Depression Scale
(GDS)[2] is probably the most widely used in research set-
tings. The original version comprises 30 items, whereas
subsequent versions have been proposed with 15, 12 and
later five items [3-5]. None of the items query somatic
complaints, rather, questions inquire about the respond-
ent's perspective on their life over the previous week.
The Minimum Data Set (MDS), created in response to the
US Omnibus Budget Reconciliation Act of 1987, aims to
provide a uniform, standardized, and comprehensive
assessment of residents in nursing homes [6]. The MDS
has undergone several revisions since its inception, and is
currently undergoing another revision process. Section E
of MDS version 2.0 assesses 16 depression symptoms that
capture verbal and non-verbal indicators of depressed
mood or anxiety as perceived by nursing home staff. A
summary scale, the Depression Rating Scale (DRS), uses a
subset of seven of these symptoms and has been shown to
be a reliable and valid measure of depression among nurs-
ing home residents [7]. The MDS DRS is therefore, by
nature of its ubiquity, potentially the most widely availa-
ble depression assessment instrument for older adults in
nursing home settings.
This study compares the measurement properties of two
measures of geriatric depression: the GDS and the MDS.
The GDS is evaluated via a 15 and five item form. The
MDS is evaluated by the items located in Section E in total
and as a subset included in the Depression Rating Scale.
Methods
Participants were nursing home residents living in nine
Massachusetts nursing facilities participating in a research
study between July 1994 and March 1998. Details of the
study are described elsewhere [8]. All data used in this
study reflect baseline and pre-intervention observations.
The sample is considered representative of persons living
in nursing homes in Eastern Massachusetts. Potential par-
ticipants consented individually or by proxy to participate
in a research study, using a protocol approved by the local
Institutional Review Board. Exclusion criteria included: 1)
a terminal prognosis, 2) a projected stay of less than 90
days, or 3) health complications that prohibited contact.
Seven hundred four (n = 704) residents and/or their prox-
ies participated in the baseline assessment, representing
67% of those eligible (14% of screened residents were
ineligible). Seventy-seven percent of residents were
women, 95% were White, non-Hispanic, and the median
age was 86 years (interquartile range, 79–91 years). About
half (54%) of residents had a chart diagnosis of dementia.
Assessment of depression
Residents were evaluated with the Minimum Data Set
(MDS) Resident Assessment Instrument version 2.0 [6] as
well as a 15-item version of the Geriatric Depression Scale
(GDS-15) [2,3,9]. Trained research nurses collected the
observations. For this analysis, we also considered a 5-
item version of the GDS (GDS-5) [5]. MDS data collected
and used in this analysis included demographic and clin-
ical characteristics, level of cognitive and communicative
functioning, and symptoms of depression. We used a sim-
ple sum of all symptoms in MDS section E1, referred to as
E1SUM, as one MDS-based measure of depression. We
also used a subset of seven of these MDS symptoms to
code the MDS Depression Rating Scale (DRS) [7].
We also examined the depression symptom scales with
regard to indicators of clinically recognized depression:
chart diagnoses of depression and recent use of antide-
pressant medication. These data were also obtained by
research nurses using structured chart review forms keyed
to data elements collected with the MDS. MDS assessors
are instructed to note the presence of a disorder related to
the resident's current functional, cognitive, and behav-
ioural status, medical treatments, and risk of death [10].
Among the disorders assessed is depression. The MDS
manual is not specific with regard to clinical or diagnostic
criteria for indicating depression diagnoses. The MDS also
includes assessment of psychotropic medication use in
the seven days preceding the assessment, including anti-
depressant use. In our analyses, we compared residents
receiving any antidepressant with those receiving no
antidepressant.
Assessment of cognitive impairment
We stratified the sample into two groups based on the
severity of cognitive impairment. The impaired group
comprised residents who were comatose (MDS 2.0 item
B1 = 1), and/or with a short-term memory problem (B2a
= 1) and those who only rarely/never make themselves
understood (C4 = 3). All other residents were assigned to
the "cognitively intact" group. This decision rule matches
a screening rule for the MDS versus GDS depression symp-
tom assessment proposed in the US Centers for Medicare
& Medicaid Services' (CMS) working draft of the MDS ver-
sion 3.0 [11].
Analytic approach
We compared sample statistics and psychometric proper-
ties for each of the four depression scales across strata
defined by cognitive impairment. We evaluated missing
data by examining the proportion of residents with com-
plete data on all assessment items, and also by the propor-
tion of residents with complete data on a majority of
items in the scale. For all other analyses we substituted
missing values with the mean of the resident's non-miss-Page 2 of 8
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We examined means, standard deviations (SD), propor-
tion of residents scoring at the floor, the internal consist-
ency reliability (coefficient alpha [12], examined with and
without a row-wise mean substitution rule for missing
item responses) and the correlation among the depression
scales.
Finally, we examined the relationship of the scale scores
to clinical indicators of depression: chart diagnoses of
Table 1: Sample statistics and psychometric properties of Geriatric Depression Scale and MDS Depression Rating Scale.
Sample statistic or psychometric property Cognitively Impaired 
Group (n = 495)
Cognitively Intact 
Group (n = 209)
All Participants 
(N = 704)
Number (%) with missing data on all items
GDS-15 81 (16%) 35 (17%) 116 (16%)
GDS-5 110 (22%) 5 (2%) 115 (16%)*
E1SUM 3 (1%) 2 (1%) 5 (1%)
DRS 0 (0%) 0 (0%) 0 (0%)
Number (%) with complete data on all items
GDS-15 139 (28%) 111 (53%) 250 (36%)*
GDS-5 223 (45%) 157 (75%) 380 (54%)*
E1SUM 492 (99%) 207 (99%) 699 (99%)
DRS 494 (100%) 209 (100%) 703 (100%)
Number (%) with majority of scale items not missing
GDS-15 357 (72%) 203 (97%) 560 (80%)*
GDS-5 352 (71%) 200 (96%) 552 (78%)*
E1SUM 495 (100%) 209 (100%) 704 (100%)
DRS 495 (100%) 209 (100%) 704 (100%)
Mean* (SD)
GDS-15 4.7 (3.5) 4.9 (3.4) 4.8 (3.5)
GDS-5 2.0 (1.5) 2.1 (1.6) 1.5 (1.6)
E1SUM 3.9 (3.8) 2.7 (3.4) 3.6 (3.7)*
DRS 1.9 (2.1) 1.8 (2.3) 1.9 (2.2)
Proportion at floor
GDS-15 0.081 0.053 0.072
GDS-5 0.166 0.167 0.166
E1SUM 0.206 0.349 0.249*
DRS 0.356 0.397 0.368
Alpha – internal consistency reliability – row-wise complete cases only
GDS-15 0.799 0.781 0.791
GDS-5 0.609 0.597 0.602
E1SUM 0.695 0.738 0.708
DRS 0.542 0.672 0.583*
Alpha – internal consistency reliability – row-wise mean substitution for 
missing data†
GDS-15 0.825 0.798 0.814
GDS-5 0.663 0.634 0.651
E1SUM 0.695 0.738 0.708
DRS 0.542 0.672 0.583*
Correlation coefficients
(GDS-5, GDS-15) 0.858 0.852 0.856
(DRS, GDS-15) 0.073 0.098 0.080
(DRS, GDS-5) 0.065 0.064 0.062
(E1SUM, GDS-15) 0.068 0.096 0.072
(E1SUM, GDS-5) 0.055 0.058 0.049
(E1SUM, DRS) 0.850 0.940 0.865*
Abbreviations: GDS-15, 15-item Geriatric Depression Scale; GDS-5, 5-item Geriatric Depression Scale; DRS, Minimum Data Set (MDS) Depression 
Rating Scale; E1SUM denotes the sum of all mood and anxiety items in section E1 of the MDS; SD, standard deviation
* For each respondent, if a majority of the items were not missing, any missing item was replaced with the mean of the non-missing items.
† Missing item responses replaced with mean score for all respondents 'non-missing' on that item.Page 3 of 8
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pared the mean of the scale scores across each of four cells
formed by crossing antidepressant use and depression
diagnoses. These comparisons were also made within cog-
nitive impairment strata. Within strata, cell means were
standardized with respect to the mean and standard devi-
ation of the group of residents that neither received anti-
depressants nor had a chart diagnosis of depression. In
this way, cell mean differences can be interpreted on an
effect size metric [13]. All analyses were conducted with
STATA software (College Station, Texas).
Results
Sample statistics and missing data
Table 1 presents the sample statistics and psychometric
properties for the comparison of the GDS and the MDS
depression assessment instruments, stratified by level of
cognitive impairment. Approximately 70% of residents
were classified as cognitively impaired. Among the cogni-
tively impaired, a majority had missing values for the
GDS-derived scales (i.e., the GDS-15 and the GDS-5). A
substantial proportion (about one in six) of residents
were missing data on all GDS items. However, for the
GDS-5, about 1 in 20 of the residents without cognitive
impairment were missing data on all GDS items. On the
other hand, the presence of missing data on the MDS-
derived scales (i.e., E1SUM and DRS) was essentially nil in
both cognitive impairment groups. About a third of resi-
dents had no missing values on the GDS-15 and more
than half had missing data on the GDS-5.
On the other hand, about half of the cognitively intact
group had no missing GDS-15 scores and three-quarters
had no missing GDS-5 scores. Using an item-level missing
data mean substitution rule, predicated on a resident hav-
ing at least a majority of items present, the frequency of
missing data for scale scores diminished for the GDS-
derived scales. However, the impact of missing data
remains an important problem for GDS-derived measures
among the cognitively impaired: between one quarter and
one third of the cognitively impaired still had missing
data. All noted differences in the frequency of missing
data describe large effect sizes (in Cohen's effect size tax-
onomy [13]) and are statistically significant (P < .001).
The very high frequency of missing data for the GDS
encouraged us to examine the frequency of missing data
at the item level. We present this information in Table 2,
limiting the sample to those missing at least one but not
all GDS items. The item with the greatest frequency of
missing data was item 15 ("do you think that most people
are better off than you are") for both the cognitively
impaired group and those with better cognitive function-
ing. The item with the fewest missing values was item 5
among the cognitively impaired group ("are you in good
spirits most of the time?") and item 1 among those with-
out cognitive impairment ("are you basically satisfied
with your life?"). Although the proportion with missing
data on each item differed significantly across cognitive
impairment strata for only one item (item 9), many of the
differences across groups depict medium or larger effect
sizes (items 2, 9, 10, 12).
Table 2: Proportion of residents with missing data on individual items of the Geriatric Depression Scale. Limited to residents missing 
at least one but less than all 15 items.
Item descriptions Cognitively Impaired 
Group (n = 251)
Cognitively Intact 
Group (n = 93)
All Participants 
(N = 344)
1. Are you basically satisfied with your life?* 37 (15%) 6 (6%) 43 (13%)
2. Have you dropped many of your activities and interests? 68 (27%) 10 (11%) 78 (23%)
3. Do you feel that your life is empty? 57 (23%) 16 (17%) 73 (21%)
4. Do you often get bored?* 47 (19%) 14 (15%) 61 (18%)
5. Are you in good spirits most of the time? 30 (12%) 9 (10%) 39 (11%)
6. Are you afraid that something bad is going to happen? 44 (18%) 13 (14%) 57 (17%)
7. Do you feel happy most of the time? 35 (14%) 12 (13%) 47 (14%)
8. Do you often feel helpless?* 55 (22%) 20 (22%) 75 (22%)
9. Do you prefer to stay in your room, rather than go out and doing new things?* 88 (35%) 11 (12%) 99 (29%)
10. Do you feel you have more problems with memory than most? 80 (32%) 11 (12%) 91 (26%)
11. Do you think that it is wonderful to be alive? 48 (19%) 14 (15%) 62 (18%)
12. Do you feel pretty worthless they way you are now?* 78 (31%) 14 (15%) 92 (27%)
13. Do you feel full of energy? 64 (25%) 14 (15%) 78 (23%)
14. Do you feel that your situation is hopeless? 74 (29%) 16 (17%) 90 (26%)
15. Do you think that most people are better off than you? 110 (44%) 31 (33%) 141 (41%)
* included in GDS-5Page 4 of 8
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The means for the GDS- and MDS-derived scales were dif-
ferent between the cognitively intact and impaired groups
(Table 1). Of note, the cognitively impaired group
received higher scores on both the GDS-15 and GDS-5,
indicating higher levels of depression. While these differ-
ences were small [13] they describe statistically significant
differences (P < .05). Conversely, the cognitively intact
residents within both the DRS and E1SUM had higher
depression ratings. The difference between cognitive
impairment groups was trivial[13] and not statistically
different for the GDS (P = .79), but of moderate size[13]
and statistically significant for E1SUM (P < .001).
Floor effect
Figure 1 illustrates several characteristics of the GDS-15
and the DRS, including the floor effect. Both instruments
produce distributions with a high proportion of respond-
ents scoring zero. For the GDS-derived measures as well as
the DRS, the proportion scoring at the floor is similar for
both cognitive impairment groups. The difference in the
proportion scoring at the floor on the E1SUM measure is
moderately different between the cognitively intact and
cognitively impaired groups (P < 0.01).
Internal consistency reliability
The GDS-15 had the highest internal consistency reliabil-
ity coefficient, and the lowest was observed for the DRS.
However, this difference does not substantially exceed
that expected due to the greater scale length of the GDS-
15. Using the Spearman-Brown prophecy formula [14],
the reliability of the DRS for the total sample would be
0.72 if it had 15 similar items (instead of 7), which is
closer to that observed for the GDS-15 (for residents with
complete data). There was no statistically significant dif-
ference in the internal consistency reliability across cogni-
tive impairment groups (using the variance ratio test[15])
for the GDS-derived scales and the E1SUM. However, the
differences across cognitive impairment strata for the DRS
were statistically significant (P < .01). We also note that
the estimated internal consistency reliability can be artifi-
cially inflated by using a row-wise (i.e., person-wise)
mean substitution rule for missing data. This artificial
inflation affects GDS-derived scales but not DRS-derived
scales.
Correlation of DRS and GDS
The correlation between the GDS- and DRS- derived
measures were not statistically different from zero. All of
the differences in correlation coefficients are similar
among the cognitively impaired and cognitively intact
and not statistically different, except for the correlation of
the E1SUM and DRS (P < .001).
Relation of DRS and GDS to indicators of conspicuous 
depression
The comparison of mean depression symptom scale
scores among residents that received antidepressants and/
or had a chart diagnosis of depression, within and across
cognitive impairment strata, is reported in Table 3. For the
GDS-15, within both cognitive impairment groups, there
are trivial marginal differences in the mean score for either
a depression diagnosis or record of antidepressant use. For
the GDS-5, the mean score is somewhat higher for resi-
dents with a diagnosis or record of antidepressant use.
These differences correspond to small to moderate effect
size differences [13]. The marginal differences are not sta-
tistically significant within cognitive impairment strata,
but for the total sample the pattern of means are essen-
tially the same and are statistically significant for a depres-
sion diagnosis (P = .02) and approach significance for
antidepressant use (P = .05).
For the MDS-derived depression scales, the differences in
means associated with antidepressant use and depression
diagnoses are much more dramatic than for the GDS-
derived scales, but only among the cognitively impaired.
For both the E1SUM and DRS, the marginal differences
for depression diagnoses and antidepressant use describe
moderate to large effect sizes. These differences are
Scatter plot of 15-item Geriatric Depression Scale (GDS) and Depr ssion Rating Scale (DRS) scores am g 560 Nursing Hom  Residen s in Nine M ssa hus tts Nursing HomesFigure 1
Scatter plot of 15-item Geriatric Depression Scale (GDS) and 
Depression Rating Scale (DRS) scores among 560 Nursing 
Home Residents in Nine Massachusetts Nursing Homes.
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hand, among those residents not identified as cognitively
impaired, the marginal differences associated with antide-
pressant use and a depression diagnosis were trivial to
small and not statistically significant.
Discussion
In this study, we found that MDS- and GDS-derived
depression measures were not correlated with one
another, but were apparently adequately reliable meas-
ures of their intended construct. Thus, we infer that the
MDS and the GDS measure different aspects of nursing
home residents' depression. Each scale has specific
strengths and limitations. The practical utility of the GDS
is undermined by a very high frequency of missing data.
The proportion of GDS responses missing differs greatly
by level of cognitive functioning. The floor effect limits
both instruments. While the internal consistency
reliability is apparently greater for the GDS, this may sim-
ply be due to the greater number of items on the GDS. We
observed a weak relationship between GDS-5 scale scores
and clinical indicators of depression (diagnoses, antide-
pressant use), but the strong association between MDS-
Table 3: Mean depression scale score as a function of the presence of diagnosis of depression or receiving antidepressants. Means are 
standardized to the mean and variance of the scale score for the group without a diagnosis and who did not receive an antidepressant.
Cognitively Impaired Group (N = 495) Cognitively Intact Group (N = 209) Total (N = 704)
Depression Diagnosis Depression Diagnosis Depression Diagnosis
GDS-15 No Yes Total No Yes Total No Yes Total
Antidepressant Use No 0.00 0.14 0.02 0.00 .47 0.06 0.00 0.26 0.03
(203) (26) (229) (116) (16) (132) (319) (42) (361)
Yes 0.07 0.43 0.31 0.29 0.36 0.09 0.16 0.41 0.32
(42) (86) (128) (30) (41) (71) (72) (127) (199)
Total 0.01 0.36 0.12 0.06 0.39 0.15 0.03 0.37 0.13
(245) (112) (357) (146) (57) (203) (391) (169) (560)
GDS-5
Antidepressant Use No 0.00 0.05 0.01 0.00 0.51 0.06 0.00 0.23 0.03
(199) (23) (222) (115) (16) (131) (314) (39) (353)
Yes 0.00 0.31 0.21 0.23 0.28 0.26 0.09 0.30 0.22
(44) (86) (130) (30) (39) (69) (74) (125) (199)
Total 0.00 0.26 0.08 0.05 0.35 0.13 0.02 0.29 0.10
(243) (109) (352) (145) (55) (200) (388) (164) (552)
E1SUM
Antidepressant Use No 0.00 0.43 0.05 0.00 0.23 0.03 0.00 0.37 0.05
(295) (39) (334) (119) (18) (137) (414) (57) (471)
Yes 0.60 0.55 0.57 0.48 -.06 0.18 0.55 0.37 0.44
(62) (99) (161) (31) (41) (72) (93) (140) (233)
Total 0.11 0.52 0.22 0.10 0.04 0.08 0.10 0.37 0.18
(357) (138) (495) (150) (59) (209) (507) (197) (704)
DRS
Antidepressant Use No 0.00 0.40 0.05 0.00 0.16 0.02 0.00 0.32 0.04
(294) (39) (333) (119) (18) (137) (413) (57) (470)
Yes 0.59 0.59 0.59 0.51 -0.15 0.13 0.56 0.33 0.42
(62) (99) (161) (31) (41) (72) (93) (140) (233)
Total 0.10 0.54 0.22 0.11 -0.06 0.06 0.10 0.33 0.17
(356) (138) (494) (150) (59) (209) (506) (197) (703)
Abbreviations: GDS-15, 15-item Geriatric Depression Scale; GDS-5, 5-item Geriatric Depression Scale; DRS, Minimum Data Set (MDS) Depression 
Rating Scale; E1SUM denotes the sum of all mood and anxiety items in section E1 of the MDSPage 6 of 8
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cognitively impaired residents.
Other investigators have found a low correlation between
the DRS and the GDS and other instruments for assessing
depression, but these findings vary according to data col-
lection strategies. For example, Anderson et al found a low
correlation between the MDS DRS abstracted from resi-
dents' charts and symptom data collected with the GDS (r
= .13) and the Hamilton Depression Rating Scale (HDRS;
r = 0.24) using research interviewers [16]. Similarly, Hen-
drix et al[17] found a lack of correspondence between
MDS depression symptoms and depression classified
using a cut-point on the Cornell Scale for Depression in
Dementia (CSDD). Hendrix and colleagues attributed the
low agreement of CSDD and MDS to different data collec-
tion strategies. In their study, the CSDD was collected by
primary caregivers, while the MDS was abstracted from
the chart, and these authors suggest that the nurse admin-
istrators that completed the MDS did not consult the pri-
mary caregivers and the resident in completing the MDS
depression items. Contrast with these findings a recent
study by Ruckdeschel and colleagues [18], who converted
the MDS items into a self-report assessment device and
reported a very high correlation with depression symptom
data collected with the GDS (r = 0.71).
In our study, the assessment methods followed more
closely how they were designed to be used. The GDS was
used as a direct interview, and the MDS was used as
instructed in the MDS manual [6], and included review of
the chart, semi-structured interview with the resident,
direct caregivers, and available family members or key
informants, in order to arrive at final symptom ratings.
MDS- and GDS-derived measures were comparably relia-
ble after adjustments for test length, but were nevertheless
not very highly correlated. Therefore, whatever differenti-
ates the dimensions assessed by the two devices, it is prob-
ably an influence beyond the level of assessor training and
the rigor of the evaluation.
The fact that the MDS- and GDS-derived scales do not cor-
relate implies that the two scales evaluate different aspects
of a resident's depression. For positive MDS depression
symptom ratings, residents must visibly act by making
negative statements, be easily angered, and display unre-
alistic fears to trigger MDS symptoms. The GDS asks resi-
dents if they are satisfied with their life, feel helpless or
worthless, and are often bored. It is conceivable that GDS-
derived measures capture a brooding mental set, reflective
of a dysphoric personality trait or adjustment disorder
(for example in response to a recent change in living situ-
ation) rather than the presence of major depression.
The lack of correlation between MDS depression measures
has implications for proposed revisions to the MDS. Until
more is known about the phenomenology and clinical
validity of syndromes measured by these and other
depression measures used in long-term care settings, add-
ing self-report of symptoms of depression to the MDS is
supported by our findings. We note that both CMS's draft
revision of the MDS[11] and new versions of assessment
instruments developed for other care settings by interRAI
include a provision for self-assessment of depression [19].
However, our findings may have further implications for
CMS's revision of the MDS. The current draft of the revi-
sion calls for a sub-set of MDS section E items for those
who are cognitively impaired, and direct questioning with
the GDS-5 for those who are cognitively intact. Our find-
ings suggest a more conservative approach might be to use
both for all residents, or the MDS for all residents and the
GDS for all residents who can communicate regardless of
cognitive level. Two key findings underlie this recommen-
dation. First, we find that the GDS and MDS are not com-
plementary, but orthogonal. Second, we find no evidence
for compromised measurement properties of the GDS
among those with cognitive impairment.
Conclusions
The Geriatric Depression Scale and Minimum Data Set
mood items measure different aspects of the depression
syndrome among nursing home residents. The two meas-
ures cannot be treated as exchangeable or equivalent, and
each has it's own strengths and limitations. The GDS uses
self-report, but as a consequence suffers from a high fre-
quency of missing data. The MDS relies upon informant
ratings and therefore provides information about most
residents. Although the GDS has higher internal consist-
ency reliability than MDS, this is not beyond that expected
due to greater scale length. The MDS measures were more
strongly related to antidepressant use and record of a diag-
nosis of depression than were GDS measures. These
results highlight the fact that more psychometric research
is needed to better understand and improve the measure-
ment of depression among frail nursing home residents.
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